Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations
Edward J. Calabrese, Walter J. Kozumbo, Rachna Kapoor, Gaurav Dhawan, Pedro C. Lara, James Giordano
Topics & Concepts
ARDSCytokine stormMedicineHormesisInflammationPhenotypePopulationCoronavirus disease 2019 (COVID-19)ImmunologyOxidative stressBioinformaticsCancer researchLungBiologyPathologyInternal medicineGeneGeneticsDiseaseInfectious disease (medical specialty)Environmental healthEffects of Radiation ExposureCOVID-19 and healthcare impactsThermal Regulation in Medicine